Avidity Biosciences, Inc (RNAM) — Capital Reinvestment Ratio
Latest as of December 2023:
0.05x
Avidity Biosciences, Inc (RNAM) has a Capital Reinvestment Ratio of 0.05x as of December 2023, meaning it reinvests 0% of its operating cash flow ($16.50 Million) in capital expenditures ($863.00K). See Avidity Biosciences, Inc (RNAM) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.05x
Capex / Operating Cash Flow
Operating Cash Flow
$16.50 Million
USD
Capital Expenditures
$863.00K
USD
Data as of
Dec 2023
Most recent filing
Avidity Biosciences, Inc Capital Reinvestment Ratio (2019–2019)
This chart tracks Avidity Biosciences, Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Avidity Biosciences, Inc (2019–2019)
Year-by-year Capital Reinvestment Ratio for Avidity Biosciences, Inc from 2019 to 2019. For live market cap and broader valuation context, see market value of Avidity Biosciences, Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.09x | $2.49 Million | $235.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow